Aventis Behring GmbH
47Patents
0Active
47Granted
36Portfolio score
Filing activity: Mar 12, 1993 → Mar 4, 2004
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8197459B2 | Self-sealing medical fluid transfer device | Human Necessities | 142 | Expired |
| US6248526A | Labeled primer for use in and detection of target nucleic acids | Emerging Cross-Sectional Technologies | 72 | Expired |
| US6277961A | Stable fibrinogen solution | Chemistry; Metallurgy | 63 | Expired |
| US6737405B2 | Stabilized protein preparation and process for its preparation | Human Necessities | 38 | Expired |
| US6248365A | Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura | Human Necessities | 36 | Expired |
| US6573081B2 | Method for growing circoviruses | Chemistry; Metallurgy | 25 | Expired |
| US6482590B1 | Method for polynucleotide amplification | Chemistry; Metallurgy | 24 | Expired |
| US6310267A | Flexible wound covering based on fibrin and process for its production | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6486377B2 | Flexible wound covering based on fibrin and process for its production | Emerging Cross-Sectional Technologies | 23 | Expired |
| US6500427B1 | One-component tissue adhesive and a process for the production thereof | Human Necessities | 19 | Expired |
| US6271025A | Modified factor VIII cDNA | Human Necessities | 17 | Expired |
| US6447774B1 | Stabilized protein preparations for a tissue adhesive | Human Necessities | 16 | Expired |
| US6677440B1 | Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography | Human Necessities | 13 | Expired |
| US6117647A | Process for quantifying glycosaminoglycans in antithrombin III-containing solutions | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6139878A | Method for preparing a diafiltered stabilized blood product | Human Necessities | 11 | Expired |
| US6790410B2 | Use of a hydrogen peroxide plasma sterilization method for the mild sterilization of temperature-sensitive products | Human Necessities | 10 | Expired |
| US6204036A | Stable transglutaminase preparations and processes for their production | Human Necessities | 10 | Expired |
| US6239261A | Pasteurized, purified von Willebrand factor concentrate and a process for the preparation thereof | Chemistry; Metallurgy | 9 | Expired |
| US6800461B2 | Modified factor VIII cDNA | Human Necessities | 9 | Expired |
| US6780614B2 | Modified factor VIII cDNA and its use for the production of factor VIII | Chemistry; Metallurgy | 9 | Expired |
| US6528299B1 | Protease for activating clotting factor VII | Physics | 8 | Expired |
| US6280729A | Preparation of factor IX | Chemistry; Metallurgy | 8 | Expired |
| US6670455B1 | Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatography | Performing Operations; Transporting | 6 | Expired |
| US6537519B2 | Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases | Human Necessities | 6 | Expired |
| US7153679B2 | Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis | Physics | 5 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.